FINANCIALS

NTLA Intellia Therapeutics Inc 1652130

Income Statement
Revenue	ntla-20240930	9,111,000
Net Income	ntla-20240930	-135,712,000
Profit Margin		-1489.54%

Balance Sheet
Current Assets	710,902,000
Assets	1,173,351,000
Current Liabilities	105,683,000
Liabilities	210,736,000
Equity	962,615,000
Shares Out	101,579,000

Cash Flow Statement
Operating Cash Flow	-263,685,000
Investing Cash Flow	-25,998,000

Market Analysis
Market Cap	2,296,705,773
Price	9.50
BVPS	9.48
PB	0.99
EPS	-5.48
PS	63.02
FCF	-289,683,000

Dividends

Earnings

Find a discrepancy? The most accurate way to find company fundamental data is to view NTLA documents filed with the SEC.

NTLA Filings Clear

View A List of Tickers